Nashville, Tennessee, November 3, 2026 / PRNewswire / -- Cumberland Pharmaceuticals Inc. (Nasdaq ticker: CPIX) Today, the company announced that it will release corporate updates and its financial results for the third quarter of 2026 after the close of U.S. markets on Tuesday, November 10, 2026. The company is an innovative biopharmaceutical firm focused on developing new products for rare diseases.
The company will hold a teleconference at 4:30 p.m. Eastern Time on November 10 to discuss performance and related updates.
How to Participate in a Teleconference
- Registration link: https :// register-conf.media-server.com / register / BI0050c03d0ef44b49b8905264f4232aef
- After registration, participants can use the dial-in number provided by the system and the PIN code to join via phone. Alternatively, they can choose the “Call Me” option, and the system will automatically dial back at the start of the conference call.
- The phone conference replay will be available for one year and can be accessed through the investor relations page on the Cumberland official website, or by visiting: https :// edge.media-server.com / mmc /p/ nbwu96yx.
About Cumberland Pharmaceuticals
Cumberland Pharmaceuticals Inc is the largest biopharmaceutical company established in Tennessee, with its headquarters located in that state. The company focuses on developing innovative products that can improve the quality of patient care. It is advancing a pipeline of late-stage product candidates that cover multiple therapeutic areas and address significant unmet medical needs.
The Phase 2 clinical trial of Cumberland is currently being evaluated, and ifetroban is being studied for its effects in patients with Duchenne muscular dystrophy, systemic sclerosis, idiopathic pulmonary fibrosis, and cancer metastasis.
For more information, please visit: www.cumberlandpharma.com.
